mutLBSgeneDB |
Gene summary for DIDO1 |
![]() |
Basic gene Info. | Gene symbol | DIDO1 |
Gene name | death inducer-obliterator 1 | |
Synonyms | BYE1|C20orf158|DATF-1|DATF1|DIDO2|DIDO3|DIO-1|DIO1|dJ885L7.8 | |
Cytomap | UCSC genome browser: 20q13.33 | |
Type of gene | protein-coding | |
RefGenes | NM_001193369.1, NM_001193370.1,NM_022105.4,NM_033081.2,NM_080796.3, NM_080797.3, | |
Description | death-associated transcription factor 1death-inducer obliterator 1 | |
Modification date | 20141207 | |
dbXrefs | MIM : 604140 | |
HGNC : HGNC | ||
Ensembl : ENSG00000101191 | ||
HPRD : 10363 | ||
HPRD : 12752 | ||
Vega : OTTHUMG00000032945 | ||
Protein | UniProt: Q9BTC0 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_DIDO1 | |
BioGPS: 11083 | ||
Pathway | NCI Pathway Interaction Database: DIDO1 | |
KEGG: DIDO1 | ||
REACTOME: DIDO1 | ||
Pathway Commons: DIDO1 | ||
Context | iHOP: DIDO1 | |
ligand binding site mutation search in PubMed: DIDO1 | ||
UCL Cancer Institute: DIDO1 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
![]() |
GO ID | GO Term | PubMed ID |
Top |
Ligand binding site mutations for DIDO1 |
![]() We represented ligand binding site mutations only. (You can see big image via clicking.) ![]() |
![]() |
![]() |
LBS | AAchange of nsSNV | Cancer type | # samples | E301 | E301K | BLCA | 1 | C316 | P317Q | SKCM | 1 | C316,Y314 | I315V | STAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for DIDO1 |
![]() Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
![]() ![]() |
![]() |
![]() Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | C316 | I315V | -1.4873368 | Y314 | I315V | -1.4873368 | C316 | P317Q | -1.4157654 | E301 | E301K | -0.26304532 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
![]() |
Top |
Differential gene expression and gene-gene network for DIDO1 |
![]() |
![]() |
Top |
Top |
Phenotype information for DIDO1 |
![]() |
Disease ID | Disease name | # PubMed | Association type |
![]() |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for DIDO1 |
![]() Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
![]() |
![]() |
Drug status | DrugBank ID | Name | Type | Drug structure |
![]() |
![]() |
![]() |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
Top |
Conservation information for LBS of DIDO1 |
![]() |
LBS | AA sequence | # species | Species |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |